Latest News about NVO
Recent news which mentions NVO
Eli Lilly gets FDA approval for new obesity drug
November 08, 2023
From MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
November 08, 2023
From Benzinga
Eli Lilly chief scientific officer ‘extremely optimistic’ that major new Alzheimer’s breakthrough is coming
November 06, 2023
From MarketWatch
European Pharma Rules Overhaul, Concerns Arise Over Billions In Lost Investment, Undiscovered Treatments
November 06, 2023
Tickers
NVO
From Benzinga
Why Novo Nordisk Stock Flopped on Friday
November 03, 2023
From Motley Fool
Fed Holds Rates Steady, Powell's Cautious Stance Soothes Investors, Labor Market Softens: The Week In The Markets
November 03, 2023
From Benzinga
Insulet shares rebound after results top estimates
November 03, 2023
From MarketWatch
Ozempic Sales Soar 56% in Q3. But Is Eli Lilly a Better Stock to Buy Than Novo Nordisk?
November 03, 2023
From Motley Fool
1 Stock-Split Stock to Buy Hand Over Fist in November, and 1 to Avoid
November 03, 2023
From Motley Fool
Wegovy Maker Novo Nordisk's Obesity, Diabetes Drug Sales Hit Whopping $22B In Nine Months, Prepares To Expand Capacity
November 02, 2023
Tickers
NVO
From Benzinga
Weight Watchers Q3 Earnings Preview: Will Ozempic Weigh Down WW Stock?
November 02, 2023
From Benzinga
7 A-Rated Tech Stocks to Buy for November
November 02, 2023
From InvestorPlace
Weight-loss drug maker reports 56% profit surge, as it continues to limit supplies
November 02, 2023
From MarketWatch
From Benzinga
These Foods Have An Ozempic-Like Effect And Could Help You Lose Weight
November 01, 2023
Tickers
NVO
From Benzinga
Ozempic Supply Is Running Low: Here's Why That Can Be A Problem
October 31, 2023
From Benzinga
From MarketWatch
Ozempic Just Shrugged Off a Challenge From Viatris. What Does This Mean for Investors?
October 31, 2023
From Motley Fool
Tickers
NVO
From Motley Fool
Benzinga Bulls And Bears: Tesla, Chevron, Eli Lilly And Dogecoin Co-founder's 3 Favorite Cryptos
October 28, 2023
From Benzinga
Is Ozempic Killing Liposuction? A Stock That Could Get Hit Hard From New Weight-Loss Drugs
October 27, 2023
From Benzinga
Diabetes stocks jump as obesity-drug recovery comes ahead of schedule, analysts say
October 27, 2023
From MarketWatch
3 Monster Buy-and-Hold Growth Stocks to Buy Right Now for $1K
October 27, 2023
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.